Review
Sep 2026
Environmental Risk Assessment in Pharmaceutical Regulation: A Comparative Review of EMA, U.S. FDA and CDSCO Guidelines.
Regulatory gaps, mainly in India, and possibilities for harmonised ERA frameworks that can safeguard global health and biodiversity by encouraging regulatory consolidation are discovered by this study.
A. Sheena, R. Rajesh, Fairoosa Thaikkat
· Therapeutic Innovation and... · 0 citations